Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 701–800 of 1,392
DeVries, J. H., Meneghini, L., Barnett, A. H., Reid, T., Dain, M., Sanofi, P., Landgraf, W., Vlajnic, A., Traylor, L., & Bergenstal, R. M. (2014) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2014.10.01.23 · Cited by 11
Inverse association between fasting plasma glucose and risk of ventricular arrhythmias
Zaccardi, F., Webb, D. R., Kurl, S., Khunti, K., Davies, M. J., & Laukkanen, J. A. (2015) · Diabetologia · doi:10.1007/s00125-015-3646-0 · Cited by 11
“9 mmol/l) to define hypoglycaemia [28], in line with the ADA and Endocrine Society consensus report [29].”
ResultInsulin glargine 300U/ml in the management of diabetes: clinical utility and patient perspectives
de Galan, B. E. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s92123 · Cited by 12
“Although this was based on a recent consensus report from the American Diabetes Association, 38 the report argued that this single threshold value, chosen mainly for pragmatic reasons, should be used as an alert value for people on medication known to cause hypoglycemia rather than as a strict separation between norma…”
Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarking
Danek, E., Earnest, A., Wischer, N., Andrikopoulos, S., Pease, A., Nanayakkara, N., & Zoungas, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-28101-w · Cited by 12
Zhou, L., Siddiqui, T., Seliger, S. L., Blumenthal, J. B., Kang, Y., Doerfler, R. M., & Fink, J. C. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.06.020 · Cited by 13
Prevalence of severe hypoglycemia in a cohort of patients with type 1 diabetes
Corrales, P. J. P., Lozano, C. A., Martínez, C. J., Jiménez, L. M. L., Segovia, A. E. S., Blasco, L. G., & Romero, F. B. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.01.011 · Cited by 13
Hoffman, E. G., Jahangiriesmaili, M., Mandel, E. R., Greenberg, C., Aiken, J., D’Souza, N. C., Pasieka, A., Teich, T., Chan, O., Liggins, R., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab189 · Cited by 11
Hypoglycemia Among Type 1 Diabetes Patients After Insulin Use in Southwest Ethiopia
Yosef, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.684570 · Cited by 13
“Hypoglycemia is a clinical and biological syndrome which is responsible for non-specific signs and symptoms, including shakiness, nervousness, sweating, chills and clamminess, dizziness, hunger and nausea, confusion, weakness, sleepiness, seizures, and loss of consciousness (18), and the symptoms are relieved upon con…”
BackgroundFrequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKD
Ushiogi, Y., Kanehara, H., & Kato, T. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000102 · Cited by 13
Fan, Y., Lau, E. S. H., Wu, H., Yang, A., Chow, E., Kong, A. P. S., Ronald, C. W., Chan, J. C. N., & Luk, A. O. Y. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100730 · Cited by 19
Cisuelo, O., Stokes, K., Oronti, I. B., Haleem, M. S., Barber, T. M., Weickert, M. O., Pecchia, L., & Hattersley, J. G. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067899 · Cited by 15
Sakane, N., Kato, K., Hata, S., Nishimura, E., Araki, R., Kouyama, K., Hatao, M., Matoba, Y., Matsushita, Y., Domichi, M., et al. (2023) · Internal Medicine · doi:10.2169/internalmedicine.0332-22 · Cited by 11
Evert, A. B., & Riddell, M. C. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.09.001 · Cited by 24
Pilemann-Lyberg, S., Thorsteinsson, B., Nørgaard, K., Zander, M., Vestergaard, H., & Røder, M. E. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.006 · Cited by 12
The impact of severe hypoglycemia on renal impairment in type 2 diabetes
Lee, Y.-L., Chen, B., Lin, K., Su, R.-W., Lee, M., Hsiao, P., & Shin, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.028 · Cited by 17
Morales, C., de Luis, D. A., de Arellano, A. R., Ferrario, M. G., & Lizán, L. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0143-x · Cited by 13
LEVIN, P. A., Zhou, S., Durden, E., Farr, A. M., Gill, J., & Wei, W. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.011 · Cited by 11
Short commentary on empagliflozin and its potential clinical impact
Hinnen, D. A. (2015) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018815578599 · Cited by 13
Vihonen, H., Kuisma, M., & Nurmi, J. (2018) · Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · doi:10.1186/s13049-018-0480-7 · Cited by 11
“9 mmol/l, in accordance with definitions by European medicines agency (EMA) and American diabetes association (ADA) [5, 6].”
MethodInfluentialDissanayake, H. A., Keerthisena, G. S. P., Gamage, K. K. K., Liyanage, J. H., Ihalagama, I. R. H. S., Wijetunga, W. M. U. A., Tillekaratne, T. A. D., Katulanda, G. W., & Katulanda, P. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0264-0 · Cited by 12
“This approximates the threshold for activation of counter regulatory mechanisms and sympathetic stimulation [13].”
BackgroundFreemantle, N., Bonadonna, R. C., Gourdy, P., Mauricio, D., Müller‐Wieland, D., Bigot, G., Ciocca, A., Mauquoi, C., Rollot, M., & Bonnemaire, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033659 · Cited by 11
Changes in Management of Type 2 Diabetes Before and After Severe Hypoglycemia
Vijayakumar, P., Liu, S., McCoy, R. G., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0458 · Cited by 11
“Severe hypoglycemia in patients with diabetes is an adverse drug event that is associatedwithpooroutcomes, suchas cardiovascular events, falls, high rehospitalization rates, and increased mortality (1,2).”
BackgroundSpontaneous and iatrogenic hypoglycemia in cystic fibrosis
Hicks, R. A., Marks, B. E., Oxman, R., & Moheet, A. A. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100267 · Cited by 15
Bailey, N. C., Dimsits, J., Hammer, M., Kendall, D. M., & Bailey, T. S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0367 · Cited by 12
Sliding scale insulin use in a national cohort study of nursing home residents with type 2 diabetes
Lam, K., Gan, S., Nguyen, B., Jing, B., & Lee, S. J. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17771 · Cited by 11
“Hypoglycemia was evaluated as any major hypoglycemic episode (glucose < 54 mg/dl) or any minor hypoglycemic episode (glucose 54 - < 70 mg/dl) during the week.(22,25,26)”
BackgroundKhunti, K., Berković, M. C., Ludvik, B. H., Moberg, E., Lekdorf, J. B., Gydesen, H., & Pedersen‐Bjergaard, U. (2018) · Diabetic Medicine · doi:10.1111/dme.13662 · Cited by 12
Woo, V. C., Bell, A., CLEMENT, M. A., Noronha, L., Tsoukas, M. A., Camacho, F., Traina, S., Georgijev, N., Culham, M. D., Rose, J. B., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13573 · Cited by 10
“9 mmol/L), a level above the plasma glucose concentration at which hypoglycaemic symptoms occur.(38) In our study, irrespective of different background AHA regimens (mono, dual or triple therapy, and in combination with insulin or other AHAs), the incidence of severe hypoglycaemia was very low (<1%) and occurred mainl…”
BackgroundGarg, S. K., Wernicke‐Panten, K., Wardęcki, M., Kramer, D., Delalande, F., Franek, E., Sadeharju, K., Monchamp, T., Miossec, P., Mukherjee, B., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0008 · Cited by 11
Psychological Factors and Diabetes Mellitus
Pouwer, F., & Speight, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch56 · Cited by 12
Aleppo, G., Parkin, C. G., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., Umpierrez, G. E., Forlenza, G. P., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0196 · Cited by 11
Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults With Incident Type 2 Diabetes
Zhong, V. W., Juhaeri, J., Cole, S. R., Shay, C. M., Gordon‐Larsen, P., Kontopantelis, E., & Mayer‐Davis, E. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01402 · Cited by 9
Glycemic control of adult patients with type 1 diabetes mellitus in Arabian Gulf Countries; PREDICT
Hafidh, K., & Abdella, N. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00946-3 · Cited by 11
“The best-case scenario of T1DM management is to extend the time of glycemic control while avoiding hypoglycemia and ketosis; or as described by the ADA workgroup “a lifetime of euglycemia without hypoglycemia” [11, 15].”
BackgroundInfluentialTzogiou, C., Wieser, S., Eichler, K., Carlander, M., Djalali, S., Rosemann, T. J., & Brändle, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108476 · Cited by 11
Technology to Reduce Hypoglycemia
Yeoh, E. C. K., & Choudhary, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815574547 · Cited by 12
Gallwitz, B., Rosenstock, J., Patel, S., von Eynatten, M., Hehnke, U., MEHLBURGER, L., Dugi, K. A., & Woerle, H. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12419 · Cited by 12
“Elderly patients with T2DM are particularly vulnerable to adverse outcomes associated with hypoglycaemia [9].”
BackgroundLyngsie, P. J., Lopes, S. H. K., & Olsen, J. (2016) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.15.68 · Cited by 10
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapies
Klonoff, D. C., Fleming, G. A., Muchmore, D. B., & Frier, B. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2883 · Cited by 11
“On the basis of 4 series, in type 1 diabetes, 4%‐10% of deaths are attributed to acute hypoglycemia.(8) These adverse consequences combine to make hypoglycemia the most important obstacle to achieving good overall glycemic control.”
BackgroundLow normal fasting glucose and risk of accidental death in Korean adults: A prospective cohort study
Yi, S., Won, Y. J., & Yi, J. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.01.005 · Cited by 10
Tsunemi, A., Sato, J., Kurita, M., Wakabayashi, Y., WASEDA, N., Koshibu, M., Shinohara, M., Ozaki, A., Nakamura, H. K., Hirano, N., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13288 · Cited by 10
Colin, I. M., Alexandre, K., Bruhwyler, J., Scheen, A. J., & Verhaegen, A. A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00866-2 · Cited by 10
“Severe hypoglycemia was defined (per American Diabetes Association guidelines) as an event that requiredtheassistanceofanotherpersontoactively administer carbohydrates, glucagon, or to take other corrective actions [19].”
BackgroundStrollo, F., Furia, A., Verde, P., Bellia, A., Grussu, M., Mambro, A., Petrelli, M. D., & Gentile, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108638 · Cited by 14
“Again, one of the methods to avoid the onset of hypoglycemia is careful and frequent monitoring of blood glucose concentrations [4].”
BackgroundMethodInfluentialWei, X., Min, Y., Yu, J.-C., Wang, Q., Wang, H., Li, S., & Su, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757061 · Cited by 11
Haluzík, M., Seufert, J., Guja, C., Bonnemaire, M., Bigot, G., Tournay, M., Kis, J. T., & Freemantle, N. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01375-8 · Cited by 11
“During the 24-week treatment period, hypoglycaemic events were reported as percentages of participants with at least one event and as annualised rates (events per patient-year), and were defined on the basis of the American Diabetes Association classification [18].”
MethodJafari, B., & Britton, M. E. (2015) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1163 · Cited by 13
Blood glucose monitoring in type 2 diabetes – Nepalese patients’ opinions and experiences
Sapkota, S., Brien, J.-A. E., & Aslani, P. (2017) · Global Health Action · doi:10.1080/16549716.2017.1322400 · Cited by 13
“ture of diabetes [3], patients with diabetes may also be susceptible to hypoglycaemia due to the nature of the disease [4] and treatment [6].”
BackgroundEvaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model
Shibata, Y., Sagara, Y., Yokooji, T., et al. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00105 · Cited by 10
Burghardt, K., Müller, U. A., Muller, N., Kloos, C., Kramer, G., Jörgens, V., & Kuniß, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0873-1465 · Cited by 11
Weant, K. A., Deloney, L. P., Elsey, G., et al. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019889444 · Cited by 10
Prevalencia de hipoglucemia grave en una cohorte de pacientes con diabetes tipo 1
Corrales, P. J. P., Lozano, C. A., Martínez, C. J., Jiménez, L. M. L., Segovia, A. E. S., Blasco, L. G., & Romero, F. B. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.01.002 · Cited by 16
Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors
Lohan, L., Clément, F., Duflos, C., Villiet, M., Castet‐Nicolas, A., Boegner, C., Avignon, A., Sultan, A., & Breuker, C. (2020) · Journal of Patient Safety · doi:10.1097/pts.0000000000000764 · Cited by 10
“The acute and long-term effects can be serious and include confusion, loss of consciousness, seizures, cognitive impairment, mood change, and even death.(1,2) Hypoglycemia also has social and psychological implications and thus may alter the quality of life.”
BackgroundInfluentialChrzanowski, J., Michalak, A., Łosiewicz, A., Kuśmierczyk-Kozieł, H., Mianowska, B., Szadkowska, A., & Fendler, W. M. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0433 · Cited by 10
Hopf, M., Kloos, C., Wolf, G., Müller, U. A., & Muller, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040571 · Cited by 11
“Severe hypoglycemia was defined as any episode requiring assistance of another person to recover [9].”
BackgroundFulcher, G. R., Jarlov, H., Piltoft, J. S., Singh, K. P., Liu, L., Mohamed, M., Nicodemus, N. A., Aljaser, S., & Kok, A. (2021) · Endocrine · doi:10.1007/s12020-021-02887-8 · Cited by 11
Li, M., Zhao, M., Yan, H., Guo, H., & Shi, B. (2023) · Nursing Open · doi:10.1002/nop2.1929 · Cited by 9
“Hypoglycemia and the fear of hypoglycemia will further reduce the treatment and nursing care compliance of patients with diabetes, leading to poor blood glucose control and related complications (Seaquist et al., 2013).”
Paul, S., Maggs, D., Klein, K., & Best, J. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12208 · Cited by 9
“There has been increasing recognition of the importance of hypoglycemia as an adverse consequence of the treatment of type 2 diabetes (T2DM).(1) Several studies following the results from UK Hypoglycaemia Study Group(2) have demonstrated severe hypoglycemia as a common problem in insulin-treated patients with T2DM, an…”
BackgroundResultMarelli, G., Avanzini, F., Iacuitti, G., Planca, E., Frigerio, I., Busi, G., Carlino, L., Cortesi, L., Roncaglioni, M. C., & Riva, E. (2015) · Journal of Diabetes Research · doi:10.1155/2015/173956 · Cited by 17
Diabetes education of patients and their entourage: out-of-hospital national study (EDUCATED 2)
Lapostolle, F., Hamdi, N., Barghout, M., Soulat, L., Faucher, A., Lambert, Y., Peschanski, N., Ricard-Hibon, A., Chassery, C., Roti, M., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0950-1 · Cited by 10
Omori, K., Kawamura, T., Misako, U., Matsuura, M., Kusama, M., Imamine, R., Watarai, A., Nakashima, E., Umemura, T., & Hotta, N. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.011 · Cited by 10
Zhang, T., Ji, L., Gao, Y., Zhang, P., Zhu, D., Li, X., Ji, J., Zhao, F., Zhang, H., & Guo, X. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0111 · Cited by 11
François, M. E., Cosgrove, S. D., Walker, N. M., Lucas, S. J. E., & Black, K. E. (2018) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2018.07.002 · Cited by 14
Jensen, M. M., & Pedersen‐Bjergaard, U. (2014) · Diabetes Management · doi:10.2217/dmt.14.54 · Cited by 10
Sinclair, A. J. (2014) · Journal of Nursing & Care · doi:10.4172/2167-1168.1000160 · Cited by 9
“The ability to mount a counterregulatory response to hypoglycaemia declines over time and the glucagon response is virtually absent in many older people [26] and when the individual is malnourished and has limited glucose stores.”
BackgroundHypoglycemia Reduction Strategies in the ICU
Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 13
Kriukova, G., Shvai, N., & Pereverzev, S. V. (2017) · IEEE International Conference on Intelligent Data Acquisition and Advanced Computing Systems: Technology and Applications (IDAACS) · doi:10.1109/idaacs.2017.8095169 · Cited by 10
Shigiyama, F., Liu, L., Nordahl, H., Suzuki, R., Yamamoto, Y., & Hirose, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01117-8 · Cited by 9
“Non-severe hypoglycaemia was defined as an event with symptoms and/or a self-monitored blood glucose value B 70 mg/dL, while severe hypoglycaemia was defined as an event requiring assistance from another person to actively administer carbohydrate or glucagon, or take another corrective action [23].”
BackgroundRi, M., Nunobe, S., Ida, S., Ishizuka, N., Atsumi, S., Hayami, M., Makuuchi, R., Kumagai, K., Ohashi, M., & Sano, T. (2021) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2021.21.e31 · Cited by 10
“Hypoglycemia was defined as a glycemic level of < 70 mg/dL [15].”
BackgroundAlgendy, A. F., Illigens, B. M. W., & Alyazeedi, A. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339331 · Cited by 12
“9 or less at the ED admission time, consistent with the ADA and The Endocrine Society definition of SH.(20) Falls and fractures are defined as any documented diagnosis of each before or at the admission time.”
MethodInfluentialBlevins, T., Raiter, Y., Sun, B., DONNELLY, C. M., Shapiro, R., Chullikana, A., Rao, A., Vashishta, L., Ranganna, G. M., & Barve, A. J. (2022) · BioDrugs · doi:10.1007/s40259-022-00554-6 · Cited by 10
Farhadnejad, H., Sadat, S., Jahromi, M. K., Teymoori, F., Tehrani, A. N., Mokhtari, E., Teymouri, H., & Mirmiran, P. (2023) · BMC Nutrition · doi:10.1186/s40795-023-00689-x · Cited by 11
“Hyperinsulinemia drastically reduces the plasma glucose concentration, which may compromise brain glucose, ∼70 mg/dl [38].”
BackgroundRecognizing and minimizing hypoglycemia: The need for individualized care
Lavernia, F., Kushner, P. R., Trence, D., Rice, D., DAILEY, G. E., & Kuritzky, L. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1086628 · Cited by 11
Buse, J. B., Han, J., Miller, S., MacConell, L., Pencek, R., & Wintle, M. E. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.896329 · Cited by 9
Lee, I., Lunt, H., Chan, H., Heenan, H. F., Berkeley, J. E., & Frampton, C. M. A. (2015) · Diabetic Medicine · doi:10.1111/dme.13025 · Cited by 8
Kim, M. K., Jung, H. S., Kwak, S. H., Cho, Y. M., Park, K. S., & Kim, S. Y. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.284 · Cited by 10
Management of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 13
Gradišer, M., Berković, M. C., & Bilić-Čurčić, I. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.036 · Cited by 9
Risk of hypoglycemia in youth with type 2 diabetes on insulin
Shahid, M., Shaibi, G. Q., Baines, H., Garcia-Filion, P. C., Gonzalez-Garcia, Z., & Olson, M. L. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0014 · Cited by 9
Iloh, G. U. P., & Amadi, A. (2018) · Journal of Health Research and Reviews · doi:10.4103/jhrr.jhrr_37_17 · Cited by 14
Choi, H. K., Nam, H. S., & Han, E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028880 · Cited by 11
Mylona, M., Liatis, S., Anastasiadis, G., Kapelios, C. J., & Kokkinos, A. D. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108038 · Cited by 10
Stefenon, P., da Silveira, A. L. M., Giaretta, L. S., Leitão, C. B., & Bauer, A. C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0521-z · Cited by 11
Stuckey, H. L., Desai, U. S., King, S. B., Popadic, L., Levinson, W., Kirson, N. Y., Hankosky, E. R., & Mitchell, B. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14745 · Cited by 10
Rafey, A., Amin, A., Kamran, M. Z., Aziz, M. I., Athar, V., Niaz, S. I., & Pieters, L. A. C. (2022) · Molecules · doi:10.3390/molecules27196715 · Cited by 13
“9 million people die every year as a result of diabetes and 50% of this death toll is a consequence of diabetic complications [3].”
BackgroundAspectos metodológicos de los procesos asistenciales integrados (PAI)
Gomis, R. F., Mata‐Cases, M., Mauricio, D., Menéndez, S. A., Muñoz, J. E., Bravo, J. J. M., Fernández-Santos, C. M., Orozco‐Beltrán, D., Rodríguez‐Mañas, L., Villalba, C. S., et al. (2017) · Revista de Calidad Asistencial · doi:10.1016/j.cali.2016.12.003 · Cited by 13
Nabrdalik, K., Kwiendacz, H., Sawczyn, T., Tomasik, A. R., Kukla, M., Masierek, M., & Gumprecht, J. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6536178 · Cited by 9
Amod, A., Buse, J. B., McGuire, D. K., Pieber, T. R., Pop‐Busui, R., Pratley, R. E., Zinman, B., Hansen, M. B., Jia, T., Mark, T., et al. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120970933 · Cited by 10
Pasciak, W., Berg, D. N., Cherlin, E. J., Fried, T. R., & Lipska, K. J. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02268-w · Cited by 12
“Severe hypoglycemia, defined as an event requiring the assistance of another person [6], is associated with significant morbidity and greater risk of death [3, 6–10], especially for older adults, as it may exacerbate or may be exacerbated by their many comorbidities.”
BackgroundRole of the Diabetes Educator in Inpatient Diabetes Management
(2017) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716683813 · Cited by 10
Zuniga-Kennedy, M., Wang, O. H., Fonseca, L. M., Cleveland, M. J., Bulger, J., Grinspoon, E. A., Hansen, D., Hawks, Z., Jung, L., Singh, S. M., et al. (2024) · The Clinical Neuropsychologist · doi:10.1080/13854046.2024.2315749 · Cited by 10
“Severe hypoglycemia can lead to confusion, loss of consciousness and even death (Seaquist et al., 2013).”
Zhou, F. L., Nicholls, C. J., Xie, L., Wang, Y., Vaidya, N., & Meneghini, L. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.73 · Cited by 7
Asian Best Practices for Care of Diabetes in Elderly (ABCDE)
Kalra, S., Dhar, M., Afsana, F., Aggarwal, P., Aye, T. T., Bantwal, G., Barua, M., Bhattacharya, S., Das, A. K., Das, S., et al. (2022) · The Review of Diabetic Studies · doi:10.1900/rds.2022.18.100 · Cited by 13
Andreopoulou, O., Kostopoulou, E., Kotanidou, E. P., Daskalaki, S., Vakka, A., Galli‐Τsinopoulou, A., & Spiliotis, B. E. (2024) · HORMONES · doi:10.1007/s42000-024-00560-z · Cited by 12
Kuniß, N., Kramer, G., Muller, N., Kloos, C., Wolf, G., & Müller, U. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0881-x · Cited by 8
“9 mmol/l [10].”
Muller, N., Lehmann, T. N., Gerste, B., Adler, J., Kloos, C., Hartmann, M., Kramer, G., Kuniß, N., & Müller, U. (2017) · Diabetic Medicine · doi:10.1111/dme.13397 · Cited by 8
Sperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Iwahori, T., Snoek, F. J., Nagai, Y., Spaepen, E., Mitchell, B. D., & Peyrot, M. F. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01211-5 · Cited by 9
“Severe hypoglycemia (SH) requires assistance from another person to actively administer carbohydrates, glucagon, or take other corrective actions [3, 4].”
BackgroundTripyla, A., Ferreira, A., Schönenberger, K. A., Näf, N. H., Inderbitzin, L. E., Prendin, F., Cossu, L., Cappon, G., Facchinetti, A., Herzig, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0454 · Cited by 10
Malmgren, S., & Åhrén, B. (2015) · Endocrinology · doi:10.1210/en.2015-1314 · Cited by 8
Meulstee, M., Whittemore, R., & Watts, S. A. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715606805 · Cited by 9
“Reflecting recent research, the ADA and the Endocrine Society have redefined hypoglycemia to include all episodes of abnormally low PG (Table 2).(24,25) Hence, not only is it the numerical PG value and the duration of hypoglycemia that may be dangerous, but frequent hypoglycemic events can interfere with daily living…”
BackgroundHypoglycemia in children with type 1 diabetes: unawareness is a concrete risk
Franchini, S., Comegna, L., Prezioso, G., & Blasetti, A. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1185400 · Cited by 10
Mathioudakis, N. N., Pronovost, P. J., Cosgrove, S. E., Hager, D. N., & Golden, S. H. (2015) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(15)41043-8 · Cited by 9
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.